Tibsovo Tablet, Film Coated
Product Images NDC 72694-617
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tibsovo (NDC 72694-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Servier Pharmaceutical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
250 mg Tablet 60-count Bottle Label (Tibsovo 02)
The text describes a graph that shows the overall survival probability of patients with AG120+zaitidine and Placsborazasiticine. The X-axis represents the number of patients at risk, and the Y-axis represents the overall survival in months. The graph shows that AG120+zaitidine has a higher survival probability than Placsborazasiticine.*
Chemical Structure (Tibsovo 03)
250 mg Tablet 60-count Carton Label (product Of Usa) (Tibsovo 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.